4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator | Patent Number 09403772

US 09403772 B2
Application Number14360991
Publication NumberUS 20150011510 A1
Pendency3 years, 8 months, 8 days
Filled DateNov 28, 2012
Priority DateNov 29, 2011
Publication DateJan 8, 2015
Expiration DateNov 28, 2031
Inventor/ApplicantsClaudio Giuliano
Claudio Pietra
Valentino J Stella
Peter Manini
Roberta Cannella
Alessio Venturini
Emanuela Lovati
Luca Fadini
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Assignments
Helsinn Therapeutics
Current
Helsinn Birex Pharmaceutials Ltd.
Current
Helsinn Healthcare Sa
Current
Helsinn Healthcare Sa
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.